Global Nuclear Medicine/Radiopharmaceuticals Market Growth 2021-2026
  • ID: 100561
  • February 4, 2021
  • 133 pages
  • LP Information

According to this latest study, the 2020 growth of Nuclear Medicine/Radiopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Nuclear Medicine/Radiopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 5317.4 million in 2019. Over the next five years the Nuclear Medicine/Radiopharmaceuticals market will register a 8.5% CAGR in terms of revenue, the global market size will reach US$ 7362.5 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine/Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Diagnostic
Therapeutic

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Oncology
Thyroid
Cardiology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption 2016-2026
2.1.2 Nuclear Medicine/Radiopharmaceuticals Consumption CAGR by Region
2.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic
2.2.2 Therapeutic
2.3 Nuclear Medicine/Radiopharmaceuticals Sales by Type
2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2021)
2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2016-2021)
2.3.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Type (2016-2021)
2.4 Nuclear Medicine/Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.5 Nuclear Medicine/Radiopharmaceuticals Sales by Application
2.5.1 Global Nuclear Medicine/Radiopharmaceuticals Sale Market Share by Application (2016-2021)
2.5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Application (2016-2021)
2.5.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Application (2016-2021)

3 Global Nuclear Medicine/Radiopharmaceuticals by Company
3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company
3.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Company (2019-2021)
3.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2019-2021)
3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company
3.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Company (2019-2021)
3.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company (2019-2021)
3.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Company
3.4 Global Manufacturers Nuclear Medicine/Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Location Distribution
3.4.2 Players Nuclear Medicine/Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Nuclear Medicine/Radiopharmaceuticals by Region
4.1 Global Nuclear Medicine/Radiopharmaceuticals by Region
4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Region
4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region
4.2 Americas Nuclear Medicine/Radiopharmaceuticals Sales Growth
4.3 APAC Nuclear Medicine/Radiopharmaceuticals Sales Growth
4.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth
4.5 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth

5 Americas
5.1 Americas Nuclear Medicine/Radiopharmaceuticals Sales by Country
5.1.1 Americas Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021)
5.1.2 Americas Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021)
5.2 Americas Nuclear Medicine/Radiopharmaceuticals Sales by Type
5.3 Americas Nuclear Medicine/Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Nuclear Medicine/Radiopharmaceuticals Sales by Region
6.1.1 APAC Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021)
6.1.2 APAC Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021)
6.2 APAC Nuclear Medicine/Radiopharmaceuticals Sales by Type
6.3 APAC Nuclear Medicine/Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Country
7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021)
7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021)
7.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type
7.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021)
8.1.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021)
8.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Nuclear Medicine/Radiopharmaceuticals Distributors
10.3 Nuclear Medicine/Radiopharmaceuticals Customer

11 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast
11.1 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Region
11.1.1 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Regions (2021-2026)
11.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Type
11.7 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Application

12 Key Players Analysis
12.1 China Isotope & Radiation
12.1.1 China Isotope & Radiation China Isotope & Radiation Company Information
12.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Offered
12.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 China Isotope & Radiation Main Business Overview
12.1.5 China Isotope & Radiation Latest Developments
12.2 Dongcheng
12.2.1 Dongcheng Company Information
12.2.2 Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Offered
12.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Dongcheng Main Business Overview
12.2.5 Dongcheng Latest Developments
12.3 Jaco
12.3.1 Jaco Company Information
12.3.2 Jaco Nuclear Medicine/Radiopharmaceuticals Product Offered
12.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Jaco Main Business Overview
12.3.5 Jaco Latest Developments
12.4 Ciaeriar
12.4.1 Ciaeriar Company Information
12.4.2 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Offered
12.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Ciaeriar Main Business Overview
12.4.5 Ciaeriar Latest Developments
12.5 Advanced Molecular-imaging Solution
12.5.1 Advanced Molecular-imaging Solution Company Information
12.5.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Offered
12.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Advanced Molecular-imaging Solution Main Business Overview
12.5.5 Advanced Molecular-imaging Solution Latest Developments
12.6 Shanghai Atom Kexing
12.6.1 Shanghai Atom Kexing Company Information
12.6.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Offered
12.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Shanghai Atom Kexing Main Business Overview
12.6.5 Shanghai Atom Kexing Latest Developments
...

13 Research Findings and Conclusion

None

None

List of Tables
Table 1. Nuclear Medicine/Radiopharmaceuticals Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Diagnostic
Table 3. Major Players of Therapeutic
Table 4. Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 5. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 6. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2021) & ($ million)
Table 7. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
Table 8. Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Type (2016-2021)
Table 9. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 10. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 11. Global Nuclear Medicine/Radiopharmaceuticals Value by Application (2016-2021)
Table 12. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
Table 13. Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Application (2016-2021)
Table 14. Global Nuclear Medicine/Radiopharmaceuticals Sales by Company (2019-2021) & (K Units)
Table 15. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2019-2021)
Table 16. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company (2019-2021)
Table 18. Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 20. Players Nuclear Medicine/Radiopharmaceuticals Products Offered
Table 21. Nuclear Medicine/Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021) (K Units)
Table 25. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 26. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 28. Americas Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 29. Americas Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 30. Americas Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 32. Americas Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 33. Americas Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 34. Americas Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 35. Americas Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 36. APAC Nuclear Medicine/Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 37. APAC Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 38. APAC Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 40. APAC Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 41. APAC Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 42. APAC Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 43. APAC Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 44. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 45. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 46. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 48. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 49. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 50. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 51. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 60. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Application (2021-2026)
Table 68. China Isotope & Radiation Basic Information, Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 69. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Offered
Table 70. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. China Isotope & Radiation Main Business
Table 72. China Isotope & Radiation Latest Developments
Table 73. Dongcheng Basic Information, Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 74. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Offered
Table 75. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Dongcheng Main Business
Table 77. Dongcheng Latest Developments
Table 78. Jaco Basic Information, Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. Jaco Nuclear Medicine/Radiopharmaceuticals Product Offered
Table 80. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. Jaco Main Business
Table 82. Jaco Latest Developments
Table 83. Ciaeriar Basic Information, Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Offered
Table 85. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. Ciaeriar Main Business
Table 87. Ciaeriar Latest Developments
Table 88. Advanced Molecular-imaging Solution Basic Information, Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Offered
Table 90. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Advanced Molecular-imaging Solution Main Business
Table 92. Advanced Molecular-imaging Solution Latest Developments
Table 93. Shanghai Atom Kexing Basic Information, Nuclear Medicine/Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Offered
Table 95. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Shanghai Atom Kexing Main Business
Table 97. Shanghai Atom Kexing Latest Developments
List of Figures
Figure 1. Picture of Nuclear Medicine/Radiopharmaceuticals
Figure 2. Nuclear Medicine/Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Nuclear Medicine/Radiopharmaceuticals Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Diagnostic
Figure 10. Product Picture of Therapeutic
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 13. Nuclear Medicine/Radiopharmaceuticals Consumed in Oncology
Figure 14. Global Nuclear Medicine/Radiopharmaceuticals Market: Oncology (2016-2021) & (K Units)
Figure 15. Nuclear Medicine/Radiopharmaceuticals Consumed in Thyroid
Figure 16. Global Nuclear Medicine/Radiopharmaceuticals Market: Thyroid (2016-2021) & (K Units)
Figure 17. Nuclear Medicine/Radiopharmaceuticals Consumed in Cardiology
Figure 18. Global Nuclear Medicine/Radiopharmaceuticals Market: Cardiology (2016-2021) & (K Units)
Figure 19. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 20. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application in 2020
Figure 21. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Company in 2020
Figure 23. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2016-2021)
Figure 24. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 25. Americas Nuclear Medicine/Radiopharmaceuticals Sales 2016-2021 (K Units)
Figure 26. Americas Nuclear Medicine/Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 27. APAC Nuclear Medicine/Radiopharmaceuticals Sales 2016-2021 (K Units)
Figure 28. APAC Nuclear Medicine/Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 29. Europe Nuclear Medicine/Radiopharmaceuticals Sales 2016-2021 (K Units)
Figure 30. Europe Nuclear Medicine/Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue 2016-2021 ($ Millions)
Figure 33. Americas Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 34. Americas Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 35. Americas Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 36. Americas Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 37. United States Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 42. APAC Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions in 2020
Figure 43. APAC Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 44. APAC Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 45. China Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 52. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 53. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 54. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 55. Germany Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 64. Egypt Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Nuclear Medicine/Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles

None

Custom Research

Looking for more specific research study and analysis? Contact our Custom Research Team

Write to Custom Research Team